Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Use this CNTA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CNTA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CNTA SEC filings page. Lician reads the product cache first so this HTML stays unique to Centessa Pharmaceuticals PLC ADR even when a live quote feed is slow.
Latest cached year on this hub. Full CNTA income, balance, and cash tables.